Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.86M | 21.32M | 21.17M | 19.93M | 19.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.76M | 60.08M | 67.88M | 56.14M | 52.98M |
| Operating Income | -64.76M | -60.08M | -67.88M | -56.14M | -52.98M |
| Income Before Tax | -57.62M | -52.79M | -59.85M | -50.75M | -46.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57.62 | -52.79 | -59.85 | -50.75 | -46.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.62M | -52.79M | -59.85M | -50.75M | -46.76M |
| EBIT | -64.76M | -60.08M | -67.88M | -56.14M | -52.98M |
| EBITDA | -64.63M | -59.96M | -44.79M | -25.52M | -10.66M |
| EPS Basic | -0.83 | -0.78 | -0.89 | -0.76 | -0.70 |
| Normalized Basic EPS | -0.52 | -0.49 | -0.55 | -0.44 | -0.40 |
| EPS Diluted | -0.83 | -0.78 | -0.89 | -0.76 | -0.70 |
| Normalized Diluted EPS | -0.52 | -0.49 | -0.55 | -0.44 | -0.40 |
| Average Basic Shares Outstanding | 279.73M | 271.16M | 270.42M | 267.79M | 266.80M |
| Average Diluted Shares Outstanding | 279.73M | 271.16M | 270.42M | 267.79M | 266.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |